Search research articles
Contact Us
Filters
Showing results (91-100 of 130) with videos related to
Page
of 13
Sort By:
Biochemical Pharmacology
|
March 27, 1998
Retention of marked sensitivity to (S)-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3,4-di hydroquin oxaline-2(1H)-thione (HBY 097) by an azidothymidine (AZT)-resistant human immunodeficiency virus type 1 (HIV-1) strain subcultured in the combined presence of quinoxaline HBY 097 and 2',3'-dideoxy-3'-thiacytidine (lamivudine)
J Balzarini, H Pelemans, G Riess, et al.
Agents and Actions
|
October 1, 1984
Apparent superiority of H2-receptor stimulation and simultaneous beta-blockade over conventional treatment with beta-sympathomimetic drugs in post-acute myocardial infarction: cardiac effects of impromidine--a new specific H2-receptor agonist-in the surviving catecholamine-insensitive myocardium
G Baumann, S B Felix, C D Heidecke, et al.
Virology
|
April 28, 1997
In vitro selection for different mutational patterns in the HIV-1 reverse transcriptase using high and low selective pressure of the nonnucleoside reverse transcriptase inhibitor HBY 097
J P Kleim, I Winkler, M Rösner, et al.
Pharmaceutical Research
|
January 1, 1994
Biodistribution of mixed fluorocarbon-hydrocarbon dowel molecules used as stabilizers of fluorocarbon emulsions: a quantitative study by fluorine nuclear magnetic resonance (NMR)
L Zarif, M Postel, B Septe, et al.
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie
|
January 1, 1982
Deleterious effects of cimetidine in the presence of histamine on coronary circulation. Possible clinical implications in anaphylactic states in individuals with coronary heart disease
G Baumann, U Loher, S B Felix, et al.
Biomaterials, Artificial Cells, and Artificial Organs
|
January 1, 1988
Formulation of highly concentrated fluorocarbon emulsions and assessment by near-total exchange perfusion of the conscious rat
C Arlen, R Follana, M Le Blanc, et al.
Journal of Virology
|
December 1, 1994
Resistance pattern of human immunodeficiency virus type 1 reverse transcriptase to quinoxaline S-2720
J Balzarini, A Karlsson, C Meichsner, et al.
American Heart Journal
|
May 1, 1981
Impaired beta-adrenergic stimulation in the uninvolved ventricle post-acute myocardial infarction: reversible defect due to excessive circulating catecholamine-induced decline in number and affinity of beta-receptors
G Baumann, G Riess, W D Erhardt, et al.
The Journal of Infectious Diseases
|
November 14, 1997
Zidovudine-resistant human immunodeficiency virus type 1 strains subcultured in the presence of both lamivudine and quinoxaline HBY 097 retain marked sensitivity to HBY 097 but not to lamivudine
J Balzarini, H Pelemans, G Riess, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 9, 1996
Selective pressure of a quinoxaline nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on HIV-1 replication results in the emergence of nucleoside RT-inhibitor-specific (RT Leu-74-->Val or Ile and Val-75-->Leu or Ile) HIV-1 mutants
J P Kleim, M Rösner, I Winkler, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 130) with videos related to
Sort By:
Page
of 13
Biochemical Pharmacology
|
March 27, 1998
Retention of marked sensitivity to (S)-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3,4-di hydroquin oxaline-2(1H)-thione (HBY 097) by an azidothymidine (AZT)-resistant human immunodeficiency virus type 1 (HIV-1) strain subcultured in the combined presence of quinoxaline HBY 097 and 2',3'-dideoxy-3'-thiacytidine (lamivudine)
J Balzarini, H Pelemans, G Riess, et al.
Agents and Actions
|
October 1, 1984
Apparent superiority of H2-receptor stimulation and simultaneous beta-blockade over conventional treatment with beta-sympathomimetic drugs in post-acute myocardial infarction: cardiac effects of impromidine--a new specific H2-receptor agonist-in the surviving catecholamine-insensitive myocardium
G Baumann, S B Felix, C D Heidecke, et al.
Virology
|
April 28, 1997
In vitro selection for different mutational patterns in the HIV-1 reverse transcriptase using high and low selective pressure of the nonnucleoside reverse transcriptase inhibitor HBY 097
J P Kleim, I Winkler, M Rösner, et al.
Pharmaceutical Research
|
January 1, 1994
Biodistribution of mixed fluorocarbon-hydrocarbon dowel molecules used as stabilizers of fluorocarbon emulsions: a quantitative study by fluorine nuclear magnetic resonance (NMR)
L Zarif, M Postel, B Septe, et al.
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie
|
January 1, 1982
Deleterious effects of cimetidine in the presence of histamine on coronary circulation. Possible clinical implications in anaphylactic states in individuals with coronary heart disease
G Baumann, U Loher, S B Felix, et al.
Biomaterials, Artificial Cells, and Artificial Organs
|
January 1, 1988
Formulation of highly concentrated fluorocarbon emulsions and assessment by near-total exchange perfusion of the conscious rat
C Arlen, R Follana, M Le Blanc, et al.
Journal of Virology
|
December 1, 1994
Resistance pattern of human immunodeficiency virus type 1 reverse transcriptase to quinoxaline S-2720
J Balzarini, A Karlsson, C Meichsner, et al.
American Heart Journal
|
May 1, 1981
Impaired beta-adrenergic stimulation in the uninvolved ventricle post-acute myocardial infarction: reversible defect due to excessive circulating catecholamine-induced decline in number and affinity of beta-receptors
G Baumann, G Riess, W D Erhardt, et al.
The Journal of Infectious Diseases
|
November 14, 1997
Zidovudine-resistant human immunodeficiency virus type 1 strains subcultured in the presence of both lamivudine and quinoxaline HBY 097 retain marked sensitivity to HBY 097 but not to lamivudine
J Balzarini, H Pelemans, G Riess, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 9, 1996
Selective pressure of a quinoxaline nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on HIV-1 replication results in the emergence of nucleoside RT-inhibitor-specific (RT Leu-74-->Val or Ile and Val-75-->Leu or Ile) HIV-1 mutants
J P Kleim, M Rösner, I Winkler, et al.
Page
of 13